金色财经报道,据AXIOS网站,OpenAI首次透露,GPT-5已展现出在真实实验室环境中协助科研的能力,意味着人工智能有望在科学实验中扮演更核心角色。尽管AI在数学和物理等领域进展迅速,但在生物学领域的重大突破却相对缓慢,因为生物学高度依赖于现实世界的实验室工作,而不仅限于计算模拟。OpenAI与生物安全初创公司Red Queen Bio合作构建了一个测试框架,评估AI模型在实验室中的表现。实验室涉及液体、化学品和生物样本等“湿”操作,以区别于以数据分析为主的“干”实验室。在实验中,GPT-5提出对分子克隆实验流程的改进建议,人类科学家执行后,将结果反馈给GPT-5,GPT-5基于反馈迭代优化方案。实验结果显示,GPT-5将一项标准分子克隆流程的效率提升了79倍。
Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to
Disclaimer.